http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0126149-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5d9f3ca41550d315642580237250c5b0 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-805 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-144444 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08J2333-12 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08J5-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-525 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08J5-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-52 |
| filingDate | 1983-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36c9570b154689939fee5d3245df1df4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1fa6f5f187d3aad129c3af4627a7647d |
| publicationDate | 1984-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0126149-A1 |
| titleOfInvention | Analytical element containing a barrier zone and process employing same |
| abstract | Multi-zone element, for quantitative analytical determination in whole blood, containing a porous dispersion zone separated from a reactive zone by a barrier zone, said barrier zone comprising a non-porous film formed from a polymer composed of: 30 to 95 % by weight of polymerized monomers of structure (I), 0.25 to 30% by weight of polymerized monomers of structure (II) and 0.1 to 50% by weight of polymerized monomers of structure (III), where R1, R3 and R5 are independently chosen from the group formed by hydrogen and methyl, R2 is an alkyl having between 1 and 16 carbon atoms, R4 and R6 are independently selected from the group formed by alkenes groups having between 1 and 6 atoms carbon, (IV), where R7 represents a hydrogen, an alkyl having between 1 and 10 carbon atoms or a cycloalkyl having between 5 and 10 carbon atoms, and M represents NR8R9H + X or SO3-X where R8 and R9 are independently selected from the group formed by hydr ogene and alkyls having between 1 and 4 carbon atoms and where X is a counterion. Method of using this element in analyzes carried out in whole blood. |
| priorityDate | 1982-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 320.